RAC.AX
Price:
$1.28
Market Cap:
$222.35M
Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limi...[Read more]
Industry
Biotechnology
IPO Date
2016-07-13
Stock Exchange
ASX
Ticker
RAC.AX
According to Race Oncology Limited’s latest financial reports and current stock price. The company's current ROE is -71.34%. This represents a change of 163.65% compared to the average of -27.06% of the last 4 quarters.
The mean historical ROE of Race Oncology Limited over the last ten years is -202.75%. The current -71.34% ROE has changed -64.82% with respect to the historical average. Over the past ten years (40 quarters), RAC.AX's ROE was at its highest in in the December 2015 quarter at 205.94%. The ROE was at its lowest in in the June 2015 quarter at -1420.84%.
Average
-202.75%
Median
-70.03%
Minimum
-1534.53%
Maximum
-7.80%
Discovering the peaks and valleys of Race Oncology Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 849.26%
Maximum Annual ROE = -7.80%
Minimum Annual Increase = -1266.93%
Minimum Annual ROE = -1534.53%
Year | ROE | Change |
---|---|---|
2024 | -75.47% | 93.82% |
2023 | -38.94% | 25.50% |
2022 | -31.02% | -32.85% |
2021 | -46.20% | -31.64% |
2020 | -67.59% | -6.73% |
2019 | -72.46% | -8.87% |
2018 | -79.52% | 7.46% |
2017 | -74.00% | 849.26% |
2016 | -7.80% | -99.49% |
2015 | -1534.53% | -1266.93% |
The current ROE of Race Oncology Limited (RAC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-48.48%
5-year avg
-51.84%
10-year avg
-202.75%
Race Oncology Limited’s ROE is greater than Imugene Limited (-95.62%), greater than Incannex Healthcare Limited (-77.78%), greater than Paradigm Biopharmaceuticals Limited (-203.64%), less than Recce Pharmaceuticals Ltd (392.94%), less than Antisense Therapeutics Limited (0%),
Company | ROE | Market cap |
---|---|---|
-95.62% | $319.85M | |
-77.78% | $65.07M | |
-203.64% | $163.56M | |
392.94% | $110.14M | |
0% | $52.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Race Oncology Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Race Oncology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Race Oncology Limited's ROE?
How is the ROE calculated for Race Oncology Limited (RAC.AX)?
What is the highest ROE for Race Oncology Limited (RAC.AX)?
What is the 3-year average ROE for Race Oncology Limited (RAC.AX)?
What is the 5-year average ROE for Race Oncology Limited (RAC.AX)?
How does the current ROE for Race Oncology Limited (RAC.AX) compare to its historical average?